Read the latest news from Northwestern University Feinberg School of Medicine’s Parkinson's Disease and Movement Disorders Center. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.
- The Chicago Skyline will be Lit in Blue in honor of Parkinson's Awareness Month from April 18 – 30th-0.3-.2015
- 05.03.2014Center study featured in the Chicago Sun Times for May 3, 2014.
- 04.02.2014Tanya Simuni, MD, medical director of Northwestern University’s Parkinson’s Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health (NIH) to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
- Long-term Clinical Outcomes After Fetal Cell Transplantation in Parkinson Disease Implications for the Future of Cell Therapy02.12.2014
Danny Bega, MD; Dimitri Krainc,MD, PhD
JAMA February 12, 2014 Volume 311, Number 6
Recognized for its approach to uncovering new therapeutic targets in the fight against Parkinson’s disease (PD), Northwestern University Feinberg School of Medicine will continue that pursuit as a National Institutes of Health Center of Excellence. The only medical school to receive new or renewed designation as a Morris K. Udall Center of Excellence for Parkinson’s Disease Research in 2013, Feinberg became the Midwest’s first site in 2003, and today is one of just 10 nationwide.